Global and United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report & Forecast 2024-2031

Report ID: 1873378 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Introduction
    1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume for the Year 2017-2028
    1.3 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume for the Year 2017-2028
    1.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics
        1.5.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends
        1.5.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
        1.5.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
        1.5.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment by Type
        2.1.1 Dominant Optic Atrophy
        2.1.2 Recessive Optic Atrophy
    2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
        2.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Type
        2.3.1 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Eye Clinics
        3.1.3 Medical Research Institute
        3.1.4 Other
    3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
        3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Application
        3.3.1 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Competitor Landscape by Company
    4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Company
        4.1.1 Top Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturer (2017-2022)
        4.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturer (2017-2022)
        4.1.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Manufacturer (2017-2022)
    4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Concentration Ratio (CR)
        4.2.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in 2021
        4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturing Base Distribution, Product Type
        4.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
        4.3.3 Date of International Manufacturers Enter into Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Company
        4.5.1 Top Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Players (2020, 2021 & 2022)
5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region
    5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size in Volume by Region (2017-2028)
        5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region: 2017-2022
        5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size in Value by Region (2017-2028)
        5.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region: 2017-2022
        5.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size YoY Growth 2017-2028
        6.1.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size YoY Growth 2017-2028
        6.3.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size YoY Growth 2017-2028
        6.4.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Alkeus Pharmaceuticals
        7.1.1 Alkeus Pharmaceuticals Corporation Information
        7.1.2 Alkeus Pharmaceuticals Description and Business Overview
        7.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.1.5 Alkeus Pharmaceuticals Recent Development
    7.2 Amgen
        7.2.1 Amgen Corporation Information
        7.2.2 Amgen Description and Business Overview
        7.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.2.5 Amgen Recent Development
    7.3 Biovista
        7.3.1 Biovista Corporation Information
        7.3.2 Biovista Description and Business Overview
        7.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.3.5 Biovista Recent Development
    7.4 Editas Medicine
        7.4.1 Editas Medicine Corporation Information
        7.4.2 Editas Medicine Description and Business Overview
        7.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.4.5 Editas Medicine Recent Development
    7.5 GenSight Biologics
        7.5.1 GenSight Biologics Corporation Information
        7.5.2 GenSight Biologics Description and Business Overview
        7.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.5.5 GenSight Biologics Recent Development
    7.6 Ixchel Pharma
        7.6.1 Ixchel Pharma Corporation Information
        7.6.2 Ixchel Pharma Description and Business Overview
        7.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.6.5 Ixchel Pharma Recent Development
    7.7 Khondrion
        7.7.1 Khondrion Corporation Information
        7.7.2 Khondrion Description and Business Overview
        7.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.7.5 Khondrion Recent Development
    7.8 Mitotech
        7.8.1 Mitotech Corporation Information
        7.8.2 Mitotech Description and Business Overview
        7.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.8.5 Mitotech Recent Development
    7.9 ProQR Therapeutics
        7.9.1 ProQR Therapeutics Corporation Information
        7.9.2 ProQR Therapeutics Description and Business Overview
        7.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.9.5 ProQR Therapeutics Recent Development
    7.10 Sanofi
        7.10.1 Sanofi Corporation Information
        7.10.2 Sanofi Description and Business Overview
        7.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.10.5 Sanofi Recent Development
    7.11 Spark Therapeutics
        7.11.1 Spark Therapeutics Corporation Information
        7.11.2 Spark Therapeutics Description and Business Overview
        7.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Products Offered
        7.11.5 Spark Therapeutics Recent Development
    7.12 Stealth BioTherapeutics
        7.12.1 Stealth BioTherapeutics Corporation Information
        7.12.2 Stealth BioTherapeutics Description and Business Overview
        7.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Stealth BioTherapeutics Products Offered
        7.12.5 Stealth BioTherapeutics Recent Development
    7.13 Usher Syndrome
        7.13.1 Usher Syndrome Corporation Information
        7.13.2 Usher Syndrome Description and Business Overview
        7.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Usher Syndrome Products Offered
        7.13.5 Usher Syndrome Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Chain Analysis
    8.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
    8.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process
    8.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Marketing
        8.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels
        8.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors
    8.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends
    Table 3. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers
    Table 4. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges
    Table 5. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints
    Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturer, 2017-2022
    Table 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Manufacturer (2017-2022) & (USD/Piece)
    Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2021)
    Table 18. Top Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
    Table 20. Date of International Manufacturers Enter into Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Alkeus Pharmaceuticals Corporation Information
    Table 43. Alkeus Pharmaceuticals Description and Business Overview
    Table 44. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 45. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product
    Table 46. Alkeus Pharmaceuticals Recent Development
    Table 47. Amgen Corporation Information
    Table 48. Amgen Description and Business Overview
    Table 49. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 50. Amgen Product
    Table 51. Amgen Recent Development
    Table 52. Biovista Corporation Information
    Table 53. Biovista Description and Business Overview
    Table 54. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 55. Biovista Product
    Table 56. Biovista Recent Development
    Table 57. Editas Medicine Corporation Information
    Table 58. Editas Medicine Description and Business Overview
    Table 59. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 60. Editas Medicine Product
    Table 61. Editas Medicine Recent Development
    Table 62. GenSight Biologics Corporation Information
    Table 63. GenSight Biologics Description and Business Overview
    Table 64. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 65. GenSight Biologics Product
    Table 66. GenSight Biologics Recent Development
    Table 67. Ixchel Pharma Corporation Information
    Table 68. Ixchel Pharma Description and Business Overview
    Table 69. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 70. Ixchel Pharma Product
    Table 71. Ixchel Pharma Recent Development
    Table 72. Khondrion Corporation Information
    Table 73. Khondrion Description and Business Overview
    Table 74. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 75. Khondrion Product
    Table 76. Khondrion Recent Development
    Table 77. Mitotech Corporation Information
    Table 78. Mitotech Description and Business Overview
    Table 79. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 80. Mitotech Product
    Table 81. Mitotech Recent Development
    Table 82. ProQR Therapeutics Corporation Information
    Table 83. ProQR Therapeutics Description and Business Overview
    Table 84. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 85. ProQR Therapeutics Product
    Table 86. ProQR Therapeutics Recent Development
    Table 87. Sanofi Corporation Information
    Table 88. Sanofi Description and Business Overview
    Table 89. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 90. Sanofi Product
    Table 91. Sanofi Recent Development
    Table 92. Spark Therapeutics Corporation Information
    Table 93. Spark Therapeutics Description and Business Overview
    Table 94. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 95. Spark Therapeutics Product
    Table 96. Spark Therapeutics Recent Development
    Table 97. Stealth BioTherapeutics Corporation Information
    Table 98. Stealth BioTherapeutics Description and Business Overview
    Table 99. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 100. Stealth BioTherapeutics Product
    Table 101. Stealth BioTherapeutics Recent Development
    Table 102. Usher Syndrome Corporation Information
    Table 103. Usher Syndrome Description and Business Overview
    Table 104. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2017-2022)
    Table 105. Usher Syndrome Product
    Table 106. Usher Syndrome Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List
    Table 110. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Picture
    Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size 2017-2028 (US$ Million)
    Figure 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2017-2028 (K Pcs)
    Figure 5. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size 2017-2028 (US$ Million)
    Figure 7. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2017-2028 (K Pcs)
    Figure 8. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered
    Figure 11. Product Picture of Dominant Optic Atrophy
    Figure 12. Product Picture of Recessive Optic Atrophy
    Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2022 & 2028
    Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2017-2028) & (K Pcs)
    Figure 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2017-2028) & (USD/Piece)
    Figure 19. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2022 & 2028
    Figure 20. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2017-2028) & (K Pcs)
    Figure 23. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2017-2028) & (USD/Piece)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Eye Clinics
    Figure 27. Product Picture of Medical Research Institute
    Figure 28. Product Picture of Other
    Figure 29. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2022 & 2028
    Figure 30. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2017-2028) & (K Pcs)
    Figure 33. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2017-2028) & (USD/Piece)
    Figure 35. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2022 & 2028
    Figure 36. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2017-2028) & (K Pcs)
    Figure 39. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2017-2028) & (USD/Piece)
    Figure 41. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 42. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 46. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 53. Asia-Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 65. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 70. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain
    Figure 75. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alkeus Pharmaceuticals
Amgen
Biovista
Editas Medicine
GenSight Biologics
Ixchel Pharma
Khondrion
Mitotech
ProQR Therapeutics
Sanofi
Spark Therapeutics
Stealth BioTherapeutics
Usher Syndrome
Frequently Asked Questions
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Flexible Power Plant

Flexible Power Plant market is segmented by region (country), players, by Type and by Application ... Read More